Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Nektar Therapeutics Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 16.14||$ 17.55|
|Low||$ 15.48||$ 9.16|
The current last sale of $15.59 is 70.20% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a biopharmaceutical company developing a pipeline of drug candidates that utilize our PEGylation and advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. Our current proprietary pipeline is comprised of drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, and immunology. Our research and development activities involve small molecule drugs, peptides and protein biologic drug candidates. We create innovative drug candidates by using our proprietary advanced polymer conjugate technologies and expertise to modify the chemical structure of pharmacophores to create new molecular entities. Polymer chemistry is a science focused on the synthesis or bonding of polymer architectures with drug molecules to alter the properties of a molecule. ... More ...
Where does NKTR fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-0.61|
|Quarterly EPS Est:||-0.2|